Funder: National Institutes of Health

Due Dates: June 16, 2025 (New) | September 7, 2025 (AIDS) | October 16, 2025 (New) | January 7, 2026 (AIDS) | February 16, 2026 (New) | May 7, 2026 (AIDS) | June 16, 2026 (New) | September 7, 2026 (AIDS) | October 16, 2026 (New) | January 7, 2027 (AIDS) | February 16, 2027 (New) | May 7, 2027 (AIDS) | June 16, 2027 (New) | September 7, 2027 (AIDS) | October 16, 2027 (New) | January 7, 2028 (AIDS)

Funding Amounts: Up to $275,000 direct costs over 2 years; no more than $200,000 in any single year; 2-year maximum project period.

Summary: Supports high-risk, early-stage exploratory research to establish feasibility and proof of concept for new technologies broadly relevant to biomedical research within the NIGMS mission.

Key Information: Applications must not include preliminary data or proof-of-concept results; focus strictly on technology development, not biological questions.